Tumor progression and metastasis

Carcinogenesis

Volumn 21, Issue 3, 2000, Pages 497-503

  Yokota, Jun ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P53;

CANCER GENETICS; GENE EXPRESSION; GENE MUTATION; METASTASIS; METASTASIS POTENTIAL; ONCOGENE; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

EID: 0034108271     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.3.497     Document Type: Review

References (73)

1. Bishop, J.M. (1991) Molecular themes in oncogenesis. Cell, 25, 235-248.
2. Land, H., Parada, L.F. and Weinberg, R.A. (1983) Cellular oncogenes and multistep carcinogenesis. Science, 222, 771-778.
3. Cavenee, W.K., Dryja, T.P., Phillips, R.A., Benedict, W.F., Godbout, R., Gallie, B.L., Murphree, A.L., Strong, L.C. and White, R.L. (1983) Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature, 305, 779-784.
4. Ponder, B. (1988) Gene losses in human tumours. Nature, 335, 400-402.
5. Rodriguez, E., Sreekantaiah, C. and Chaganti, R.S. (1994) Genetic changes in epithelial solid neoplasia. Cancer Res., 54, 3398-3406.
6. Knudson, A.G.Jr (1985) Hereditary cancer, oncogenes and antioncogenes. Cancer Res., 45, 1437-1443.
7. Friend, S.H., Bernard, R., Rogelj, S., Weinberg, R.A., Rapaport, J.M., Albert, D.M. and Dryja, T.P. (1986) A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature, 323, 643-646.
8. Fearon, E.R. (1997) Human cancer syndromes: clues to the origin and nature of cancer. Science, 278, 1043-1049.
9. Haber, D. and Harlow, E. (1997) Tumor suppressor genes: evolving definitions in the genomic age. Nature Genet., 16, 320-322.
10. Yokota, J. and Sugimura, T. (1993) Multiple steps in carcinogenesis involving alterations of multiple tumor suppressor genes. FASEB J., 7, 920-925.
11. Kohno, T. and Yokota, J. (1999) How many tumor suppressor genes are involved in human lung carcinogenesis? Carcinogenesis, 20, 1403-1410.
12. Kinzler, K.W. and Vogelstein, B. (1996) Lessons from hereditary colorectal cancer. Cell, 81, 159-170.
13. Sekido, Y., Fong, K.M. and Minna, J.D. (1998) Progress in understanding the molecular pathogenesis of human lung cancer. Biochim. Biophys. Acta, 1378, 21-59.
14. Vogelstain, B., Fearon, E.R., Hamilton, S.R., Kern, S.E., Preisinger, A.C, Leppert, M., Nakamura, Y., White, R., Smith, A.M. and Bos, J.L. (1988) Genetic alterations during colorectal-tumor development. N. Engl. J. Med., 319, 525-532.
15. Knudson, A.G.Jr (1971) Mutation and cancer statistical study of retinoblastoma. Proc. Natl Acad. Sci. USA, 68, 820-823.
16. Yokola, J., Wada, M., Shimosato, Y., Terada, M. and Sugimura, T. (1987) Loss of heterozygosity on chromosomes 3, 13 and 17 in small-cell lung carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc. Natl Acad. Sci. USA, 84, 9252-9256.
17. Fearon, E.R. and Vogelstain, B. (1990) A genetic model for colorectal tumorigenesis. Cell, 61, 759-767.
18. Ookawa, K., Sakamoto, M., Hirohashi, S., Yoshida, Y. Sugimura, T., Terada, M. and Yokota, J. (1993) Concordant p53 and DCC alterations and allelic losses on chromosomes 13q and 14q associated with liver metastasis of colorectal carcinoma. Int. J. Cancer, 53, 382-387.
19. Ishimaru, G., Ookawa, K., Yamaguchi,N., Sakamoto, M., Hirohashi, S., Muto, T. and Yokota, J. (1994) Allelic losses associated with the metastatic potential of colorectal carcinoma. Int. J. Oncol., 5, 267-273.
20. Malkosyan, S., Yasuda, J., Soto, J.L., Sekiya, T., Yokota, J. and Perucho, M. (1998) Molecular karyotype (amplotype) of metastatic colorectal cancer by unbiased arbitrarily primed PCR DNA fingerprinting. Proc. Natl Acad. Sci. USA. 95, 10170-10175.
21. Shiseki, M., Kohno, T., Nishikawa, R., Sameshima, Y., Mizoguchi, H. and Yokota, J. (1994) Frequent allelic losses on chromosomes 2q, 18q and 22q in advanced non-small cell lung carcinoma. Cancer Res., 54, 5643-5648.
22. Shiseki, M., Kohno, T., Adachi, J., Okazaki, T, Otsuka, T., Mizoguchi, H., Noguchi, M., Hirohashi, S. and Yokota, J. (1996) Comparative allelotype of early and advanced stage non-small cell lung carcinomas. Genes Chromosom. Cancer, 17, 71-77.
23. Thorstensen, L., Qvist, H., Nesland, J.M., Giercksky, K.-E. and Lothe, R.A. (1996) Allelotype profiles of local recurrences and distant metastases from colorectal-cancer patients. Int. J. Cancer, 69, 452-456.
24. Saric, T., Brkanac, Z., Troyer, D.A., Padalecki, S.S., Sarosdy, M., Williams, K. and Abadesco, L. (1999) Genetic pattern of prostate cancer progression. Int. J. Cancer, 81, 219-224.
25. Young, J., Leggett, B., Ward, M., Thomas, L., Buttenshaw, R., Searle, J. and Chenevix-Trench, G. (1993) Frequent loss of heterozygosity on chromosome 14 occurs in advanced colorectal carcinomas. Oncogene, 8, 671-675.
26. Takei, K., Kohno, T., Hamada, K., Takita, J., Noguchi, M., Matsuno, Y, Hirohashi, S., Uezato, H. and Yokota, J. (1998) A novel tumor suppressor locus on chromosome 18q involved in the development of human lung cancer. Cancer Res., 58, 3700-3705.
27. Jen, J., Kim, H., Piantadosi, S., Liu,Z.-F., Levitt, R.C., Sistonen, P., Kinzler, K.W., Vogelstein, B. and Hamilton, S.R. (1994) Allelic loss of chromosome 18q and progression in colorectal cancer. N. Engl. J. Med., 331, 213-221.
28. Muraoka, M., Konishi, M., Kikuchi-Yanoshita, R., Tanaka, K., Shitara, N., Chong, J.M., Iwama, T. and Miyaki, M. (1996) p300 gene alterations in colorectal and gastric carcinomas. Oncogene, 12, 1565-1569.
29. Brodeur, G.M., Seeger, R.C., Schwab, M., Varmus, H.E. and Bishop, J.M. (1984) Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science, 224, 1121-1124.
30. Seeger, R.C., Brodeur, G.M., Sather, H., Dalton, A., Siegel, S.E., Wong, K.Y. and Hammond, D. (1985) Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med., 313, 1111-1116.
31. Slamon, D.J., Clark, G.M., Wong, S.G., Levin, W.J., Ullrich, A. and McGuire, W.L. (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235, 177-182.
32. Slamon, D.J., Godolphin, W., Jones, L.A. et al. (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, 244, 707-712.
33. Ha proto-oncogenes in cancers are frequent and show clinical correlation. Science, 231, 261-265.
34. Yokota, J., Wada, M., Yoshida, T., Noguchi, M., Terasaki, T, Shimosato, Y., Sugimura, T. and Terada, M. (1988) Heterogeneity of lung cancer cells with respect to the amplification and rearrangement of myc family oncogenes. Oncogene, 2, 607-611.
35. Rodenhius, S. and Slebos, R.J. (1992) Clinical significance of ras oncogene activation in human lung cancer. Cancer Res., 52, 2665-2669.
36. Herman, J.G., Merlo, A., Mao, L., Lapidus, R.G., Issa, J.P., Davidson, N.E., Sidransky, D. and Baylin, S.B. (1995) Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55, 4525-4530.
37. Nigro, J.M., Baker, S.J., Preisinger, A.C. et al. (1989) Mutations in the p53 gene occur in diverse human tumour types. Nature, 342, 705-708.
38. Harris, C.C. (1993) p53: at the crossroads of molecular carcinogenesis and risk assessment. Science, 262, 1980-1981.
39. INK4 protein is restricted to the subset of lung cancer lines that retains wild type RB. Oncogene, 9, 3375-3378.
40. Kelley, M.J., Nakagawa, K., Steinberg, S.M., Mulshine, J.L, Kamb, A. and Johnson, B.E. (1995) Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines. J. Natl Cancer Inst., 17, 756-761.
41. Ionov, J., Peinado, M.A., Markhosyan, S., Shibata, D. and Perucho, M. (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature, 363, 558-561.
42. Perucho, M. (1996) Cancer of the microsatellite mutator phenotype. Biol. Chem., 377, 675-684.
43. Lengauer, C., Kinzler, K.W. and Vogelstein, B. (1998) Genetic instabilities in human cancers. Nature, 396, 643-649.
44. Markowitz, S., Wang, J., Myeroff, L. et al. (1995) Inactivation of the type II TGF-p receptor in colon cancer cells with microsatellite instability. Science, 268. 1336-1338.
45. Rampino, N., Yamamoto, H., Ionov, Y., Li, Y., Sawai, H., Reed, J.C. and Perucho, M. (1997) Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science, 275, 967-969.
46. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. (1991) p53 mutations in human cancer Science, 253, 49-53.
47. Greenblatt, M.S., Bennet, W.P., Hollstein, M. and Harris, C.C. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878.
48. Fidler, I.J. (1973) Selection of successive tumor lines for metastasis. Nature, 242, 148-149.
49. Fidler, I.J. (1990) Critical factors in the biology of human cancer metastasis: twenty-eighth G. H. A. Clowes memorial award lecture. Cancer Res., 50, 6130-6138.
50. Bernstein, S.C. and Weinberg, R.A. (1985) Expression of the metastatic phenotype in cells transfected with human metaslatic tumor DNA. Proc. Natl Acad. Sci. USA, 82, 1726-1730. [Published erratum appears in Proc. Natl Acad. Sci. USA (1988) 85, 5581.]
51. Hayle, A.J., Darling, D.L., Taylor, A.R. and Tarin, D. (1993) Transfection of metastatic capability with total genomic DNA from human and mouse metastatic tumour cell lines. Differentiation, 54, 177-189.
52. Liang, P. and Pardee, A.B. (1992) Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science, 257, 967-971.
53. Leone, A., Flatow, U., King, C.R., Sandeen, M.A., Margulies, I.M.K., Liotta, L.A. and Steeg, P.S. (1991) Reduced tumor incidence, metastatic potential and cytokine responsiveness of nm23-transfected melanoma cells. Cell, 65, 25-35.
54. Hashimoto, Y., Shindo-Okada, N., Tani, M., Nagamachi, Y., Takeuchi, K., Shiroishi, T., Toma, H. and Yokota, J. (1998) Expression of the Elm/ gene, a novel gene of CCN family, suppresses in vivo tumor growth and metastasis of K-1735 murine melanoma cells. J. Exp. Med., 187, 289-296.
55. Davies, B.R., Davies, M.P.A., Gibbs, F.E.M., Barraclough, R. and Rudland, P.S. (1993) Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1. Oncogene, 8, 999-1008.
56. Toh, Y., Pencil, S.D. and Nocolson, G.L. (1994) A novel candidate metastasis-associated gene, mtal, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. J. Biol. Chem., 269, 22958-22963.
57. Dong, J.T., Lamb, P.W., Rinker-Schaeffer, C.W., Vukanovic, J., Ichikawa, T., Issac, J.T. and Barret, J.C. (1995) KAII, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science, 268, 884-886.
58. Lee, J.-H. and Welch, D.R. (1997) Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-I. Cancer Res., 57, 2384-2387.
59. Habets, G.G.M., Scholtes, E.H.M., Zuydgeest, D., van der Kamman, R.A., Stam, J.C., Berns, A. and Collard, J.G. (1994) Identification of an invasion-inducing gene, Tiam-I. that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell, 77, 537-549.
60. Nicolson, G.L. (1987) Tumor cell instability, diversification and progression to the metastatic phenotype: From oncogene to oncofetal expression. Cancer Res., 47, 1473-1487.
61. Kerbel, R.S., Viloria-Petit, A., Okada, F. and Rak, J. (1998) Establishing a link between oncogenes and tumor angiogenesis. Mol. Med., 5, 286-295.
62. Guilford, P. (1999) E-cadherin downregulation in cancer: fuel on the fire? Mol. Med. Today, 5, 172-177.
63. Van Meir, E.G., Polverini, P.J., Chazin, V.R., Su Huang, H.J., de Tribolet, N. and Cavenee, W.K. (1994) Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nature Genet., 8, 171-176.
64. Nishimori, H., Shiratsuchi, T., Urano, T., Kimura, Y., Kiyono, K., Tatsumi, K., Yoshida, S., Ono, M., Kuwano, M., Nakamura, Y. and Tokino, T. (1997) A novel brain-specific p53-target gene, BAII, containing thrombospondin type 1 repeats inhibits experimental angiogenesis. Oncogene, 15, 2145-2150.
65. Bouvet, M., Ellis, L.M., Nishizaki, M., Fujiwara, T., Liu, W., Bucana, C.D., Fang, B., Lee, J.J. and Roth, J.A. (1998) Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. Cancer Res., 58, 2288-2292.
66. Chin, L., Tam, A., Pomerantz, J., Wong, M., Holash, J., Bardeesy, N., Shen, Q., O'Hagen, R., Pantginis, J., Zhou, H., Horner, J.W.II, Cordon-Cardo, C., Yancopoulos, G.D. and Depinho, R.A. (1999) Essential role for oncogenic ras in tumour maintenance. Nature, 400, 468-472.
67. Hahn, W., Counter, C.M., Lundberg, A.S., Beijersbergen, R.L., Brooks, M.W. and Weinberg, R.A. (1999) Creation of human tumour cells with defined genetic elements. Nature, 400, 464-468.
68. Duggan, D.J., Bittner, M., Chen, Y., Meltzer, P. and Trent, J.M. (1999) Expression profiling using cDNA microarrays. Nature Genet., 21, 10-14.
69. Marra, M.A., Hillier, L. and Waterston, R.H. (1998) Expressed sequence tags - ESTablishing bridges between genomes. Trends Genet., 14, 4-7.
70. The Sanger Centre and the Washington University Genome Sequence Center (1998) Towards a complete human genome sequence. Genome Res., 8, 1097-1108.
71. Lander, E.S. (1999) Array of hope. Nature Genet., 21, 3-4.
72. Sidransky, D. (1997) Nucleic-acid based methods for the detection of cancer. Science, 278, 1054-1058.
73. Klein, C.A., Schmidt-Kittler, O., Schardt, J.A., Pantel, K., Speicher, M.R. and Riethmuller, G. (1999) Comparative genomic hybridization, loss of heterozygosity and DNA sequence analysis of single cells. Proc. Natl Acad. Sci. USA, 96, 4494-4499.